{"version":"1.0","type":"link","title":"Canagliflozin Is a Novel Androgen Receptor Pathway Inhibitor for Castrate-Sensitive and Castrate-Resistant Prostate Cancer.","author_name":"Ali A 외","author_url":"https://prs-insight.online/author/Ali%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/130477","thumbnail_width":1200,"thumbnail_height":630}